The Cooper Companies/$COO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Cooper Companies
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Ticker
$COO
Sector
Primary listing
Employees
16,000
Headquarters
Website
COO Metrics
BasicAdvanced
$14B
33.52
$2.04
1.02
-
Price and volume
Market cap
$14B
Beta
1.02
52-week high
$107.95
52-week low
$61.78
Average daily volume
2.8M
Financial strength
Current ratio
2.116
Quick ratio
0.908
Long term debt to equity
29.108
Total debt to equity
29.67
Interest coverage (TTM)
7.40%
Profitability
EBITDA (TTM)
1,127.7
Gross margin (TTM)
66.96%
Net profit margin (TTM)
10.08%
Operating margin (TTM)
18.37%
Effective tax rate (TTM)
34.04%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
3.79%
Return on equity (TTM)
5.01%
Valuation
Price to earnings (TTM)
33.517
Price to revenue (TTM)
3.371
Price to book
1.63
Price to tangible book (TTM)
4.76
Price to free cash flow (TTM)
33.114
Free cash flow yield (TTM)
3.02%
Free cash flow per share (TTM)
2.065
Growth
Revenue change (TTM)
6.35%
Earnings per share change (TTM)
13.47%
3-year revenue growth (CAGR)
7.91%
10-year revenue growth (CAGR)
8.38%
3-year earnings per share growth (CAGR)
-2.08%
10-year earnings per share growth (CAGR)
7.35%
What the Analysts think about COO
Analyst ratings (Buy, Hold, Sell) for The Cooper Companies stock.
Bulls say / Bears say
Second-quarter revenue rose 6% year-over-year to $1,002.3 million with CooperVision up 5% and CooperSurgical up 8%, while non-GAAP diluted EPS grew 14% to $0.96, driven by strength in silicone hydrogel lenses and surgical portfolios (Reuters).
Gross margin expanded to 68% from 67% and operating margin improved to 18% from 17%, underpinned by efficiency gains, mix improvement, and targeted expense leverage in both segments (Reuters).
Returned $40.6 million to shareholders via share repurchases in Q2 under its existing program and raised its fiscal 2025 non-GAAP EPS guidance to $4.05–$4.11, underscoring confidence in free cash flow generation and earnings power (Reuters)
Lowered its full-year revenue forecast to $4.07–$4.10 billion for fiscal 2025, down from $4.11–$4.15 billion, after reporting a noticeable drop in demand in parts of Asia and a slowdown in the Americas, cutting organic growth expectations to 5%–6% (Reuters).
The pure-play e-commerce segment in Asia Pacific underperformed significantly, mirroring earlier weakness in China and smaller regional markets, highlighting ongoing demand headwinds for CooperVision lenses (Reuters).
Shares plunged 11.21% in after-hours trading following the lowered forecast, reflecting investor concern over a slowing growth trajectory and mixed execution in key markets (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
COO Financial Performance
Revenues and expenses
COO Earnings Performance
Company profitability
COO News
AllArticlesVideos
Stock Of The Day: Time To Buy Cooper Companies?
Benzinga1 month ago
Cooper Companies Posts Downbeat Sales, Joins NetApp, Urban Outfitters, Nvidia And Other Big Stocks Moving Lower In Thursday Pre-Market Session
Benzinga2 months ago
Analysts Love These 3 Companies Reporting Earnings This Week
MarketBeat2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Cooper Companies stock?
The Cooper Companies (COO) has a market cap of $14B as of October 13, 2025.
What is the P/E ratio for The Cooper Companies stock?
The price to earnings (P/E) ratio for The Cooper Companies (COO) stock is 33.52 as of October 13, 2025.
Does The Cooper Companies stock pay dividends?
No, The Cooper Companies (COO) stock does not pay dividends to its shareholders as of October 13, 2025.
When is the next The Cooper Companies dividend payment date?
The Cooper Companies (COO) stock does not pay dividends to its shareholders.
What is the beta indicator for The Cooper Companies?
The Cooper Companies (COO) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.